"Aspirin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
| Descriptor ID |
D001241
|
| MeSH Number(s) |
D02.455.426.559.389.657.410.595.176
|
| Concept/Terms |
Aspirin- Aspirin
- Acetylsalicylic Acid
- Acid, Acetylsalicylic
- 2-(Acetyloxy)benzoic Acid
|
Below are MeSH descriptors whose meaning is more general than "Aspirin".
Below are MeSH descriptors whose meaning is more specific than "Aspirin".
This graph shows the total number of publications written about "Aspirin" by people in this website by year, and whether "Aspirin" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 8 | 11 |
| 1996 | 9 | 2 | 11 |
| 1997 | 11 | 3 | 14 |
| 1998 | 3 | 2 | 5 |
| 1999 | 5 | 6 | 11 |
| 2000 | 4 | 8 | 12 |
| 2001 | 4 | 4 | 8 |
| 2002 | 5 | 12 | 17 |
| 2003 | 15 | 8 | 23 |
| 2004 | 7 | 8 | 15 |
| 2005 | 7 | 9 | 16 |
| 2006 | 7 | 10 | 17 |
| 2007 | 7 | 11 | 18 |
| 2008 | 12 | 13 | 25 |
| 2009 | 16 | 15 | 31 |
| 2010 | 12 | 7 | 19 |
| 2011 | 13 | 13 | 26 |
| 2012 | 17 | 16 | 33 |
| 2013 | 15 | 9 | 24 |
| 2014 | 24 | 18 | 42 |
| 2015 | 25 | 16 | 41 |
| 2016 | 23 | 19 | 42 |
| 2017 | 29 | 12 | 41 |
| 2018 | 28 | 13 | 41 |
| 2019 | 26 | 24 | 50 |
| 2020 | 31 | 23 | 54 |
| 2021 | 18 | 23 | 41 |
| 2022 | 6 | 35 | 41 |
| 2023 | 7 | 31 | 38 |
| 2024 | 12 | 13 | 25 |
| 2025 | 2 | 0 | 2 |
Below are the most recent publications written about "Aspirin" by people in Profiles.
-
Obstructive sleep apnea and cerebral small vessel disease in community-based older people: an aspirin in reducing events in the elderly imaging substudy. Sleep. 2025 Feb 10; 48(2).
-
Polygenic risk, aspirin, and primary prevention of coronary artery disease. Eur Heart J Cardiovasc Pharmacother. 2025 Feb 08; 11(1):84-91.
-
Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage Occlusion. J Am Coll Cardiol. 2024 Sep 03; 84(10):889-900.
-
Contribution of Clinical Trial Event Data by Data Source: A Prespecified Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. 2024 Sep 01; 9(9):852-857.
-
Daily low-dose aspirin and blood pressure in community-dwelling older adults. J Clin Hypertens (Greenwich). 2024 Oct; 26(10):1188-1195.
-
Effect of a Cardiovascular Polypill on Poststroke Cognition Among Ghanaians: Secondary Analysis of a Randomized Clinical Trial. J Am Heart Assoc. 2024 Aug 06; 13(15):e034346.
-
Short- and long-term impact of aspirin cessation in older adults: a target trial emulation. BMC Med. 2024 07 29; 22(1):306.
-
Effects of low-dose acetylsalicylic acid on the inflammatory response to experimental sleep restriction in healthy humans. Brain Behav Immun. 2024 Oct; 121:142-154.
-
Effect of Peripheral Interventions in Patients with Peripheral Artery Disease Receiving Rivaroxaban and Aspirin: Analyses from the XATOA Registry. Eur J Vasc Endovasc Surg. 2024 Dec; 68(6):784-795.
-
Contemporary Prestroke Dual Antiplatelet Use and Symptomatic Intracerebral Hemorrhage Risk After Thrombolysis. JAMA Neurol. 2024 Jul 01; 81(7):722-731.